RECRUITING

International Multicentric Observational Study to Characterize Subpopulations of Patients with Autism Spectrum Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication

Official Title

International, Multicentric, Observational Study to Characterize Subpopulations of Patients with Autism Spectrum Disorder

Quick Facts

Study Start:2022-10-13
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05590715

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:12 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants previously diagnosed with ASD (DSM-5)
  2. * Available well-documented health records within the first 2 years of life
  3. * Participants must have a parent or reliable caregiver who agrees to provide information about the participant
  4. * Participants willing and consenting or assenting to participate.
  1. * Episode of fever (i.e. ≥100.5 °F or ≥ 38 °C) or clinically significant illness without fever (as judged by the investigator), within 10 days before any study assessment.
  2. * If the investigator assesses any unwillingness or any medical condition that may prevent the subject from completing this study.

Contacts and Locations

Study Contact

Gregory Bonfils, PhD
CONTACT
+41 22 545 12 42
clinical@stalicla.com
Eric Painbeni, PhD
CONTACT
+41 22 545 12 42
clinical@stalicla.com

Principal Investigator

Paulo Fontoura, MD, PhD
STUDY_DIRECTOR
Stalicla SA

Study Locations (Sites)

SARRC
Phoenix, Arizona, 85006
United States
California Neuroscience Research
Sherman Oaks, California, 91403
United States
The Angel Medical Research
Miami Lakes, Florida, 33016
United States
BioPhase Research
Miami, Florida, 33137
United States
Rush University Medical Center
Chicago, Illinois, 60612
United States
University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders
Columbia, Missouri, 65211
United States
Golden Hearts Diagnostic
Alamogordo, New Mexico, 88210
United States
Red Oak Psychiatry Associates
Houston, Texas, 77090
United States
Alpine Research Organization
Clinton, Utah, 84015
United States

Collaborators and Investigators

Sponsor: Stalicla SA

  • Paulo Fontoura, MD, PhD, STUDY_DIRECTOR, Stalicla SA

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-10-13
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2022-10-13
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Autism Spectrum Disorder